U.S. Markets closed

Anthera Pharmaceuticals, Inc. (ANTH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.35-0.02 (-1.46%)
At close: 4:00PM EDT
People also watch
AVEOAPRIFOLDALIMCLSN
Full screen
Previous Close1.37
Open1.35
Bid1.30 x 2700
Ask1.38 x 100
Day's Range1.30 - 1.39
52 Week Range1.20 - 27.36
Volume237,492
Avg. Volume299,834
Market Cap14.72M
Beta2.83
PE Ratio (TTM)-0.17
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Anthera's Blisibimod Positive in Phase II Extension Study
    Zacks23 days ago

    Anthera's Blisibimod Positive in Phase II Extension Study

    Anthera's (ANTH) blisibimod passes test in an extended phase II study to prove efficacy for IgA nephropathy treatment. The study also shows a trend toward preservation of renal function.

  • Associated Presslast month

    Anthera beats 2Q profit forecasts

    The Hayward, California-based company said it had profit of 3 cents per share. Losses, adjusted for non-recurring gains, came to 86 cents per share. The results beat Wall Street expectations. The average ...

  • Associated Press4 months ago

    Anthera reports 1Q loss

    The Hayward, California-based company said it had a loss of $2.03 per share. In the final minutes of trading on Wednesday, the company's shares hit $2.26. A year ago, they were trading at $28. _____ This ...